Sunday, November 22, 2026

American Public Education And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 13, 2021

Automated market report from our archive (2020-2024), published before source-traceability. How we work

American Public Education  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - American Public Education (APEI), Neurocrine Biosciences (NBIX), Globus Medical (GMED) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. American Public Education (APEI)

76.3% sales growth and 7.15% return on equity

American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education.

American Public Education's sales growth this year is expected to be 25.2% and 56.7% for next year.

Year-on-year quarterly revenue growth grew by 18.7%, now sitting on 335.71M for the twelve trailing months.

Volume

Today's last reported volume for American Public Education is 292935 which is 261.87% above its average volume of 80949.

American Public Education's sales growth is a negative 0% for the current quarter and 76.3% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 94.4% and negative -17%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.15%.

Volatility

American Public Education's last day, last week, and last month's current intraday variation average was 2.52%, 2.57%, and 2.95%, respectively.

American Public Education's highest amplitude of average volatility was 3.95% (day), 3.44% (last week), and 4.21% (last month), respectively.

American Public Education's Stock Yearly Top and Bottom Value

American Public Education's stock is valued at $18.89 at 05:22 EST, way under its 52-week high of $39.19 and above its 52-week low of $18.11.

American Public Education's Moving Average

American Public Education's worth is way under its 50-day moving average of $24.12 and way below its 200-day moving average of $28.12.

2. Neurocrine Biosciences (NBIX)

30.2% sales growth and 42.19% return on equity

Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders.

Neurocrine Biosciences's sales growth this year is expected to be 9% and 23.4% for next year.

Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 1.05B for the twelve trailing months.

Volume

Today's last reported volume for Neurocrine Biosciences is 775507 which is 8.85% above its average volume of 712428.

Neurocrine Biosciences's sales growth for the next quarter is 30.2%. The company's growth estimates for the current quarter and the next is 193.5% and negative -80.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 42.19%.

Volatility

Neurocrine Biosciences's last day, last week, and last month's current intraday variation average was 1.20%, 1.77%, and 1.25%, respectively.

Neurocrine Biosciences's highest amplitude of average volatility was 3.02% (day), 4.63% (last week), and 3.36% (last month), respectively.

Neurocrine Biosciences's Stock Yearly Top and Bottom Value

Neurocrine Biosciences's stock is valued at $79.68 at 05:22 EST, way below its 52-week high of $120.27 and above its 52-week low of $79.01.

Neurocrine Biosciences's Moving Average

Neurocrine Biosciences's value is way below its 50-day moving average of $95.40 and way under its 200-day moving average of $95.52.

3. Globus Medical (GMED)

9.5% sales growth and 11.93% return on equity

Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders.

Globus Medical's sales growth this year is expected to be 20.6% and 10% for next year.

Year-on-year quarterly revenue growth grew by 6.3%, now sitting on 941.53M for the twelve trailing months.

Volume

Today's last reported volume for Globus Medical is 398762 which is 12.78% below its average volume of 457219.

Globus Medical's sales growth for the next quarter is 9.5%. The company's growth estimates for the current quarter and the next is a negative 19% and 8.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.93%.

Volatility

Globus Medical's last day, last week, and last month's current intraday variation average was 0.77%, 1.31%, and 1.30%, respectively.

Globus Medical's highest amplitude of average volatility was 3.27% (day), 2.51% (last week), and 2.97% (last month), respectively.

Globus Medical's Stock Yearly Top and Bottom Value

Globus Medical's stock is valued at $63.79 at 05:22 EST, way under its 52-week high of $84.23 and above its 52-week low of $58.87.

Globus Medical's Moving Average

Globus Medical's value is way below its 50-day moving average of $75.99 and way under its 200-day moving average of $73.40.

4. Target Corporation (TGT)

8% sales growth and 45.98% return on equity

Target Corporation operates as a general merchandise retailer in the United States.

Target Corporation's sales growth this year is expected to be 11.7% and 1.7% for next year.

Year-on-year quarterly revenue growth grew by 9.5%, now sitting on 100.33B for the twelve trailing months.

Volume

Today's last reported volume for Target Corporation is 7739890 which is 146.67% above its average volume of 3137700.

Target Corporation's sales growth is a negative 0% for the current quarter and 8% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 0.4% and 6.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 45.98%.

Volatility

Target Corporation's last day, last week, and last month's current intraday variation average was 0.26%, 0.95%, and 1.69%, respectively.

Target Corporation's highest amplitude of average volatility was 1.29% (day), 1.94% (last week), and 2.56% (last month), respectively.

Target Corporation's Stock Yearly Top and Bottom Value

Target Corporation's stock is valued at $243.84 at 05:22 EST, under its 52-week high of $268.98 and way higher than its 52-week low of $166.82.

Target Corporation's Moving Average

Target Corporation's worth is under its 50-day moving average of $248.22 and above its 200-day moving average of $233.69.

Previous days news about Target Corporation(TGT)

  • According to Business Insider on Wednesday, 8 December, "The company announced a partnership with Target Corporation (NYSE:TGT) for inclusion in physical stores and on the Target.com website. "
  • According to Business Insider on Thursday, 9 December, "Analyst Robert Ohmes compared grocery prices at conventional supermarkets Kroger Co (NYSE:KR) and Publix to prices at specialty grocers Sprouts Farmers Market Inc (NASDAQ:SFM) and Amazon.com, Inc.(NASDAQ:AMZN) subsidiary Whole Foods as well as mass retailers Walmart Inc (NYSE:WMT) and Target Corporation (NYSE:TGT)."

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 13 Dec 2021
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.